$11.50
-0.77 (-6.28%)
Performance
1D
—
1W
—
1M
—
3M
-39.47%
6M
-39.47%
1Y
-39.47%
YTD
-39.47%
Open$12.16
Previous Close$12.27
Day High$12.16
Day Low$10.30
52W High$19.95
52W Low$11.64
Volume—
Avg Volume625.2K
Market Cap2.04B
P/E Ratio—
EPS—
SectorN/A
Technical Indicators
Full analysis →
RSI (14)
28.7
Oversold
Analyst Ratings
Strong Buy
11 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.33B | 1.25B | 1.09B |
| Net Income | 91.57M | 76.97M | 69.27M |
| Profit Margin | 6.9% | 6.2% | 6.3% |
| EBITDA | 140.27M | 127.47M | 113.65M |
| Free Cash Flow | 141.26M | 81.25M | 73.26M |
| Rev Growth | -6.7% | -0.7% | -9.4% |
| Debt/Equity | 0.18 | 0.17 | 0.15 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $7.15 | -3.77% | — | 7.06B |
| DMII | Drugs Made In America Acquis | $9.97 | +0.00% | — | 656.41M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.18B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.55 | -0.28% | 63.3 | 608.59M |
| CEPF | Cantor Equity Partners-Cl A | $10.20 | -0.29% | 356.7 | 584.55M |
| BCSS | Bain Capital Gss Inv- A | $10.11 | +0.10% | — | 593.34M |